Indian Pharmacopoeia Commission (IPC) which is the national co-ordinating centre for Pharmacovigilance Programme of India (PvPI) has been re-designated as the WHO collaborating centre to help Word Health Organisation (WHO) in locations of pharmacovigilance(PV) in public overall health programmes and regulatory services in low and middle revenue nations (LMIC) in Asia and beyond.
Through this centre, IPC will help WHO to create relevant tools and recommendations for enhancing Pharmacovigilance (PV) practice in low and middle revenue nations (LMIC) in Asia.
Pharmacovigilance is the science and activities associated to the detection, assessment, understanding and prevention of adverse effects due to a medicine or vaccine.
IPC is an autonomous institution of the Union Health Ministry tasked to set requirements of drugs in the nation.
It was initial designated on July 18, 2017 for 5 years and has once more been designated till July 18, 2025.
It is also aimed at supporting WHO by contributing to its work to make capacity of WHO Member States to establish higher top quality pharmacovigilance systems for health-related items such as health-related devices.
This will additional help WHO by contributing to its work guiding nations in the integration of pharmacovigilance in public overall health programmes such as Tuberculosis, Neglected Tropical Diseases, Vector Borne Diseases, HIV-AIDS Immunization Programme and regulatory concerns.
There are 7 WHO collaborative centre globally in pharmacovigilance and WHO collaborative centre for PV in public overall health and regulatory services from India will serve as the 8th centre.
Uppsala Monitoring Centre (UMC) was the initial WHO Collaborating Centre to be established for pharmacovigilance when, in 1978, the scientific and technical duty of the WHO programme for international drug monitoring was transferred to Sweden.
The WHO programme for international drug monitoring is a group of more than 150 nations that share the vision of safer and more powerful use of medicines. UMC has been accountable for the technical and operational elements of the programme because 1978.
The UMC is involved closely with WHO HQ in initiatives in advertising pharmacovigilance in HIV/AIDS, malaria and tuberculosis remedy programmes that big donors such as Global Fund and Gates Foundation amongst other folks are supporting in nations exactly where only rudimentary systems for pharmacovigilance exist.
The WHO Collaborating Centre will work in the locations of pharmaceuticals (such as crucial drugs and medicines) and overall health systems study and development. Types of activities involved by the Centre would be instruction and education, development and application of proper technologies offering technical suggestions to WHO.
IPC also frequently updates the requirements of drugs frequently needed for remedy of illnesses prevailing in India. It publishes official documents for enhancing Quality of Medicines by way of adding new and updating current monographs in the kind of Indian Pharmacopoeia (IP). It additional promotes rational use of generic medicines by publishing National Formulary of India. IP prescribes requirements for identity, purity and strength of drugs basically needed from the overall health care point of view of human beings and animals. IPC also gives IP Reference Substances (IPRS) which act as a fingerprint for identification of an write-up below test and its purity as prescribed in IP.